"Seven months after the FDA placed two trials of Salarius Pharmaceuticals’ lead asset seclidemstat in rare cancer indications on hold in the wake of a patient death, the regulator has given the green light for one of the studies to proceed.."

https://www.fiercebiotech.com/biotech/salariu...ient-death

So, they had a patient DIE yet the FDA lets them proceed after 7 months.

How long has CYDY had the hold?